AI-powered Startup QuantHealth Secures $15M to Revolutionize Clinical Drug Trials in the US

Israeli startup QuantHealth secured $15 million in Series A funding to expand its AI-powered clinical drug trials to the US. Utilizing AI, the platform forecasts trial risks, enhancing patient response and optimizing trials. Backed by a vast dataset encompassing 350 million patients, 700,000 biomedical graphs, and clinical trials, QuantHealth's model demonstrates 86% accuracy in outcome prediction, potentially revolutionizing drug development and trial success.